Francisco Leon - Dec 22, 2022 Form 4 Insider Report for Provention Bio, Inc. (PRVB)

Role
Chief Scientific Officer
Signature
/s/ Thierry Chauche, as attorney-in-fact
Stock symbol
PRVB
Transactions as of
Dec 22, 2022
Transactions value $
-$14,574
Form type
4
Date filed
12/27/2022, 04:51 PM
Previous filing
Dec 9, 2022
Next filing
Dec 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVB Common Stock Options Exercise $3.92K +1.57K +0.1% $2.50* 1.57M Dec 22, 2022 Direct
transaction PRVB Common Stock Sale -$15.7K -1.57K -0.1% $10.00 1.57M Dec 22, 2022 Direct F1
transaction PRVB Common Stock Options Exercise $938 +375 +0.02% $2.50* 1.57M Dec 23, 2022 Direct
transaction PRVB Common Stock Sale -$3.75K -375 -0.02% $10.00 1.57M Dec 23, 2022 Direct
holding PRVB Common Stock 1M Dec 22, 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVB Stock Option (right to buy) Options Exercise $0 -1.57K -0.29% $0.00 540K Dec 22, 2022 Common Stock 1.57K $2.50 Direct F2
transaction PRVB Stock Option (right to buy) Options Exercise $0 -375 -0.07% $0.00 540K Dec 23, 2022 Common Stock 375 $2.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.005 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
F2 The option is fully vested.